Member Info for Tattyhead61

I reckon his best mate Prince Andrew is putting him up to it .

Marsden does look on the ropes though. Think Katie's kidney punch of not being bothered to interview the clown has finished him off . Sincerely hope so .

Hope not ,the sp recovered late on .

Wouldn't surprise me if he phoned in sick .

Synairgen do have form for recruiting when not necessary, but I am sure they will find odd jobs to do around the place until / if/ when / maybe they will be needed..
After all ,its not them paying the salaries eh ?

What ? Buy the company easily for £300mil and save another £30 mil on the currency rate .Thats sounds ripe for a deal and bring it on .

Mr costs ,volume is low because most of us are stuck with these damm shares .If todays RNS had briefly stuck a quid on the SP .I'd have been out so there was 67600 of volume . Assuming of course anybody was daft enough to pay £1.24 on a piece of ancient news .

That was a splendid reply Gunton

Because that's not me however,he was the only one over there with his feet planted firmly on the ground .He has berated Marsden since day one and he's been proven right .Thats really difficult for you pretend scientists to take in ..
I have never been able to tolerate incompetence. Mistakes yes but down right incompetence no .
I suspect a few on here fall into the category of incompetant in their own chosen field .Qualled up to teeth but totally useless in application .You probably relate to Marsden and co as " They are trying to do their best " .You probably try as well
But..........!
The drug may be worth something ,the company isn't full stop ..

£50/ a share that costs.
You stand to make £50

Lol

I also thought the position had been filled but apparently they weren't prepared to clean toilets ,wash the excecs cars and do a turn as canteen lady until Synairgen could actually find them work to do in their own field ,unlike the other new recruits who are doing all above plus landscaping the gardens ,and sanding down and antifouling Marsdens boat .

Hes winding you all up ya dafties.

Jeez ,that AGM was a sham .Gorbals couldn't have organised a better PR ****fest . The highlight being a very old man shuffled in his chair when a question about long covid materialised.
Maybe he shuffled because he needed potty ..
FFS ! It was a sham kangaroo court but the main talking point could only be ...
Why are poly tolerating this , or are they on the verge of fist ******* the lot of us with some deal they have pre arranged .
It makes no sense why poly are so placid unless...

MC .you are bang on the money on all counts but why keep harping on and on .Yeh its true we cant just walk away and p!$$ thousands away like some of the balloons on here suggest ( like its what they'd do ).As it stands and as it has for the last few years .SNG001 has potential to succeed in the market .Unfortunately the management and to a great extent the scientists do not have the potential to succeed .Removing Marsden and Shaw ( why do we need a CEO and a chairman for a board of 10 ( again why so many? )who president over a company of 14 ?, may stimulate activity from big pharma but thats a maybe .
Big question that keeps hammering at me is why AZ are not back in the game ? They wrote off millions but there surely must have been contingencies to step back in should a different scenario than asthma presented itself .It did ( covid ) and they didn't and even at this hour they could quite easily offer £1.50 / share and own the drug for £300 million which is a give away ..
Who wouldn't sell now for £1.50 ?

Get a room you two.

Behave yourself please .

Indian summer me thinks

But again I ask politely .Once the company knew of the additional soc ,would this be price sensitive info that required a Rns to inform investors .?
Synairgen must have agreed on all points and provided additional safety data to guarantee all soc was non detrimental to SNG001 regarding safety .This was a P3 not P2 trial so all safety protocols must have been accepted and possibly in vitro safety data supplied stating remdes and dexy had no adverse reactions .This must have been sorted out out well before trial commencement wouldn't you think ?its not done overnight .
.

To those more familiar with the workings of bio/ pharma , was the inclusion of SOC to our trial not in the realms of being price sensitive info and warranting of a rns to convey this critical info to shareholders ??? And couldn't the same be assumed as and when the company received the futility data ? Both sets of info were deliberately held back from investors as it was Synairgens own trial so they must of been informed of the Soc inclusion ..
Yet another set of questions that were conveniently " not asked" at the AGM or were they ? .